Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation – Irreconcilable Differences?

Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation – Irreconcilable Differences?

Mar 16, 2018

Article

Author, American Journal of Law and Medicine, February 16, 2018

Despite the U.S. substantially outspending peer high income nations with almost 18% of GDP dedicated to health care, on any number of statistical measurements from life expectancy to birth rates to chronic disease,1 the U.S. achieves inferior health outcomes. In short, Americans receive a very disappointing return on investment on their health care dollars, causing economic and social strain.2 Accordingly, the debates rage on: what is the top driver of health care spending? Among the culprits: poor communication and coordination among disparate providers, paperwork required by payors and regulations, well-intentioned physicians overprescribing treatments, drugs and devices, outright fraud and abuse, and medical malpractice litigation.

Click the PDF above to read the full article.

Meet The Team

Michael W. King Shareholder T 303.223.1130 mking@bhfs.com